Cargando…
MD-ALL: an Integrative Platform for Molecular Diagnosis of B-cell Acute Lymphoblastic Leukemia
B-cell acute lymphoblastic leukemia (B-ALL) consists of dozens of subtypes defined by distinct gene expression profiles (GEPs) and various genetic lesions. With the application of transcriptome sequencing (RNA-seq), multiple novel subtypes have been identified, which lead to an advanced B-ALL classi...
Autores principales: | Gu, Zhaohui, Hu, Zunsong, Jia, Zhilian, Liu, Jiangyue, Mao, Allen, Han, Helen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120769/ https://www.ncbi.nlm.nih.gov/pubmed/37090504 http://dx.doi.org/10.21203/rs.3.rs-2798895/v1 |
Ejemplares similares
-
PAX5 alterations in B-cell acute lymphoblastic leukemia
por: Jia, Zhilian, et al.
Publicado: (2022) -
Pericardial Relapse of Acute Lymphoblastic Leukemia (ALL)
por: Maslov, Diana V., et al.
Publicado: (2021) -
The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades
por: Jabbour, Elias, et al.
Publicado: (2023) -
Inter-Platform comparability of microarrays in acute lymphoblastic leukemia
por: Mitchell, Stephanie A, et al.
Publicado: (2004) -
Sensitivity to Pain in Children With Acute Lymphoblastic Leukemia (ALL)
por: Firoozi, Manijeh, et al.
Publicado: (2012)